Cryptogenic fibrosing alveolitis (Idiopathic pulmonary fibrosis)
- What is Cryptogenic fibrosing alveolitis?
- Statistics on Cryptogenic fibrosing alveolitis
- Risk Factors for Cryptogenic fibrosing alveolitis
- Progression of Cryptogenic fibrosing alveolitis
- How is Cryptogenic fibrosing alveolitis Diagnosed?
- Prognosis of Cryptogenic fibrosing alveolitis
- How is Cryptogenic fibrosing alveolitis Treated?
- Cryptogenic fibrosing alveolitis References
- Drugs/Products Associated with Cryptogenic fibrosing alveolitis
What is Cryptogenic fibrosing alveolitis?
Cryptogenic fibrosing alveolitis (Idiopathic pulmonary fibrosis) is a disease of the lung.The lungs are composed of air passages, starting from the trachea (or windpipe) which divides into a left and right main bronchus, which keep dividing until they become bronchioles, and finally terminating into alveoli. The alveoli are small folded membranes shaped like a cluster of grapes. They are the interface between the air and blood stream and that is where gas exchange takes place.The function of the alveoli is dependent on the alveolar wall which is a thin membrane, allowing for oxygen and carbon dioxide to move freely across it. CFA is a disease affecting both the walls and the interior of alveoli. It causes fibrosis of the alveolar walls, which impairs gas exchange. It is an idiopathic disease - meaning at this stage it is not known what causes it. It is important to note that a lot of other diseases may cause lung fibrosis other than CFA - ie where a causative factor is known.
Statistics on Cryptogenic fibrosing alveolitis
This is the most common form of diseases of the category: "interstitial lung disease". It affects between 5-26 in every 100,000 individuals, usually between the ages of 40 - 60 years. The incidence of CFA is rising.
Risk Factors for Cryptogenic fibrosing alveolitis
Although a causative factor has not yet been found, it appears that genetic predisposition to the disease is important. There is also an association between CFA and exposure to wood and metal dust.Other diseases which may cause lung fibrosis include:
Progression of Cryptogenic fibrosing alveolitis
It is thought that the disease begins with inflammation of the alveoli. After a while, this inflammation in the walls and alveolar spaces is replaced by fibrous tissue. This fibrosis spreads progressively to include the whole lung, making it stiff, solid, and ineffective. The rate at which this process occurs is hard to predict: over many years for some people, whereas in others fibrosis may develop in a matter of weeks.Over time complications such as pulmonary hypertension, cor pulmonale and respiratory failure set in.The natural history of other causes of fibrosis may differ in the rate of progression and whether there is continual exposure to the causative factor - for example if the offending drug is stopped - the fibrosis will stop progressing.
How is Cryptogenic fibrosing alveolitis Diagnosed?
Prognosis of Cryptogenic fibrosing alveolitis
CFA has a high morbidity and mortality with only about half of all patients surviving to 5 years; the acute form has a higher mortality. Lung transplantation is most successful in younger patients, with 50% 3 year survival. Lung fibrosis due to other causes has a variable prognosis.
How is Cryptogenic fibrosing alveolitis Treated?
This is a difficult disease to treat effectively.
Cryptogenic fibrosing alveolitis References
 Cotran RS, Kumar V, Collins T. Robbins Pathological Basis of Disease Sixth Ed. WB Saunders Company 1999. pp735-36 Kumar P, Clark M. Clinical Medicine. Fourth Ed. WB Saunders, 1998. pp813-15 Talley NJ, O'Connor S. A guide to physician examinations. Third Ed. MacClennan & Petty, 1996.
Drugs/Products Used in the Treatment of This Disease:
- Azahexal (Azathioprine)
- Azamun (Azathioprine)
- Cysporin (Cyclosporin)
- Panafcortelone (Prednisolone)
- Solone (Prednisolone 5mg, 25mg)
|Modified: 6/2/2008||Created: 23/5/2003|
List Diseases by Medical Area
Australia’s leading source for trustworthy medical information written by health professionals.
Please be aware that we do not give advice on your individual medical condition,
Parenting information is available at Parenthub.com.au
|^ Back to Top|